BlueYard Capital
Edit

BlueYard Capital

https://www.blueyard.com
Last activity: 04.02.2025
Active
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Portfolio
5
Mentions
29
Investment Type: Venture Capital

Portfolio 5

DateNameWebsiteTotal RaisedLocation
18.07.2023Tromero Lt...tromero.org$2MUnited Kin...
17.07.2023Rapidatarapidata.ai$1.75MSwitzerlan...
06.04.2023Sensible B...sensible.bio$4.2MUnited Kin...
11.01.2023Visolisvisolisbio.com$8MUnited Sta...
07.04.2016deepstream...deepstreamhub.com$1MGermany, B...

Mentions in press and media 29

DateTitleDescription
04.02.2025Castelion: Defense Manufacturing Company Raises $100 MillionCastelion – a new defense manufacturer helping America and its allies preserve peace through deterrence with long-range hypersonic strike weapons – announced it has raised $100 million in debt and equity financing. And with rising tensions ...
29.01.2025Weapons Startup Castelion Strikes $100M Series A Big money for defense1 Shares Email Facebook Twitter LinkedIn Castelion, a defense manufacturer developing long-range hypersonic strike weapons, raised a $100 million Series A in a mix of debt and equity. The El Segundo, California-based startup creates what it...
19.12.2024bit.bio raises $30 Million led by M&G Investmentsbit.bio raises $30 Million led by M&G Investments to focus on tools for the research, drug discovery and cell therapy markets. Jonathan Milner appointed Interim CEO; Mark Kotter assumes Vice Chairman role as Company expands Board with d...
10.10.2024clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging TherapiesWhat You Should Know: – clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation. – The seed fundin...
29.04.2024Transcripta Bio: $10 Million Raised To Speed Up Drug Discovery With Lower RiskTranscripta Bio, a company focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel, announced its launch with $10 million in funding. Transcripta Bio co-founder, ...
06.04.2024Biofidelity Secures €22M in Funding: A Game-Changer in Genomic TechnologyCambridge-based Biofidelity, a genomic technology company, has just locked in a hefty €22M in funding, propelling its total funding to a staggering €55.3M. This cash injection, led by key investors like Octopus Ventures and Agilent Technolo...
03.04.2024Biofidelity Raises $24M in FundingBiofidelity, a Cambridge, UK- and Morrisville, NC-based genomic technology company, raised $24M in funding. Backers included Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures. Led by Dr. Barnaby Balmforth, CEO,...
07.08.2023Dutch cultivated meat startup Meatable raises $35m Series B, gears up for market entry in 2024Dutch cultivated meat startup Meatable has raised $35 million in a series B round led by Agronomics, taking its total funding to $95 million as it gears up to launch pork sausages and dumplings in Singapore next year. The round includes $17...
17.07.2023Rapidata banks CHF 1.5 million
04.07.2023Dutch firm VSParticle raises €14.5 million to scale its material discovery innovationVSParticle began life as a long-term research project in TU Delft where Aaike van der Vugt (CEO) worked on it as a Master's student before collaborating with his professor Andreas Schmidt-Ott, co-founder and CTO Tobias Pfeiffer, and co-foun...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In